Skip to content
Home/Companies/HealthTech/Affect Therapeutics
AT

Affect Therapeutics

HealthTech·United States·Active·3yr hold

Affect Therapeutics is a HealthTech company, headquartered in United States.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Affect Therapeutics?

Affect Therapeutics is currently owned by LifeArc through LifeArc Ventures (1992 vintage), since 2023.

Hand-verified · updated 2026-05-31

LifeArc
Investor
LifeArc
LifeArc Ventures · 1992 · Life Sciences VC

Key facts

HQUnited States
SectorHealthTech
StatusActive

More from LifeArc Ventures

Other portfolio companies in the same fund.

Fluid Biomed
Active
MedTechCanada· 2024
Cytospire Therapeutics
Active
BiotechUK· 2023
Maxion Therapeutics
Active
BiotechUK· 2023
Ozlo Sleep
Active
HealthTechUnited States· 2023
RQ Biotechnology
Active
BiotechUK· 2022
Surgery Hero
Exited 2025
HealthTechUK· 2022
to

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

Paladin
Active
Ring CapitalFrance
Theraclion
Exited
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Glowday
Active
Averroes CapitalUK· 2026
Data refreshed weekly · Sourced from public filings